Chemours Company
CC
Market Cap$2.31B
Close$
$-3.56
123.6% downside
Current Fair Value
123.6% downsideOvervalued by 123.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.31 Billion |
|---|---|
| Enterprise Value | $2.29 Billion |
| Dividend Yield | $0.68 (4.38%) |
| Earnings per Share | $0.58 |
| Beta | 1.59 |
| Outstanding Shares | 150,238,691 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.51 |
|---|---|
| PEG | 0.86 |
| Price to Sales | 0.39 |
| Price to Book Ratio | 15.09 |
| Enterprise Value to Revenue | 0.39 |
| Enterprise Value to EBIT | -24.64 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 2.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Chemours Company
7,000 employees
CEO: Mark Vergnano The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemi...